GIFLF:OTCMKTS
Grifols SA Class A
11,13Â US$
0,00%
(0,00) 1K
15-sen, 15:11:14 (GMT-4) · USD
search
Barcha belgilar
| Belgi | Narxi | Oʻzgartirishlar | Dinamika (%) |
|---|
insights_autoGIFLF tikeri uchun statistika yaratilmoqda...
Bozor kapitali
6,59Â mlrd
Oʻrtacha hajm
543,00
Hajmi
0,00
52 haftalik eng yuqori
12,90Â US$
52 haftalik eng past
10,13Â US$
Beta
0,90
Muomaladagi aksiyalar
426,13Â mln
Xodimlar soni
25Â ming
Bozor kapitali
6,59Â mlrd
Oʻrtacha hajm
543,00
Hajmi
0,00
52 haftalik eng yuqori
12,90Â US$
52 haftalik eng past
10,13Â US$
Beta
0,90
Muomaladagi aksiyalar
426,13Â mln
Xodimlar soni
25Â ming
Yangiliklar
Internet manbalari va yangilik hamkorlarimizdan
AD HOC NEWS
·
1 kun oldin
Grifols stock ends the week at EUR 9.88 within a EUR 9.73-9.97 range
AD HOC NEWS
·
2 kun oldin
Grifols signed a 40 GWh PPA and Grifols stock gained 1.22 percent
Profil
Grifols, S.A. is a global healthcare company and leading producer of plasma-derived medicines founded in Barcelona, Catalonia, Spain, in 1909. With a workforce of over 23,800 employees, Grifols serves more than 110 countries and regions and maintains a direct presence in over 30.
Principally a producer of blood plasma–based products and other biopharmaceuticals, the company also operates in transfusion medicine, supplying devices, instruments and reagents for clinical testing laboratories, as well as clinical diagnostic technologies. Furthermore, it provides biological supplies for life-science research, clinical trials and the manufacturing of pharmaceutical and diagnostic products. It has a portfolio on four therapeutic areas: immunology, infectious diseases, pulmonology and critical care. Wikipedia
Grifols SA Class A haqida